Citi analyst Patrick Cunningham lowered the firm’s price target on Westlake (WLK) to $93 from $100 and keeps a Buy rating on the shares as part of a Q3 earnings preview for the commodity chemicals group. The firm reduced Q3 and Q4 EBITDA estimates by up to 12% citing weak seasonal demand growth and inventory surplus
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WLK:
- Westlake Corporation: Hold Rating Amid Revised Earnings, Market Challenges, and Inflationary Pressures
- JPMorgan healthcare analysts hold an analyst/industry conference call
- Westlake price target raised to $78 from $73 at JPMorgan
- Westlake Corporation to Acquire ACI/Perplastic Group
- Westlake to acquire global compounding solutions businesses of ACI, no terms